Health
Benefit from delayed 2nd Pfizer jab: study – Corowa Free Press
Pfizer’s COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study suggests.The study released on Friday is the first to directly compare immune responses of the Pfizer shot from the three-week dosing interval tested in clinical trials, and the extended 12-week interval that British officials recommend in order to give more vulnerable people at least some protection quickly.
After Britain…
-
General20 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Noosa News16 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General9 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News9 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership